Cargando…

FiO(2) Before Surfactant, but Not Time to Surfactant, Affects Outcomes in Infants With Respiratory Distress Syndrome

Aim: To establish the impact of oxygen requirement before surfactant (SF) and time from birth to SF administration on treatment outcomes in neonatal respiratory distress syndrome (RDS). Methods: We conducted a post-hoc analysis of data from a prospective cohort study of 500 premature infants treated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kruczek, Piotr, Krajewski, Paweł, Hożejowski, Roman, Szczapa, Tomasz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pediatrics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520978/ https://www.ncbi.nlm.nih.gov/pubmed/34671585 http://dx.doi.org/10.3389/fped.2021.734696

Ejemplares similares

Implementation of less invasive surfactant administration in clinical practice—Experience of a mid-sized country
por: Szczapa, Tomasz, et al.
Publicado: (2020)

Intraventricular Hemorrhage in Premature Infants with Respiratory Distress Syndrome Treated with Surfactant: Incidence and Risk Factors in The Prospective Cohort Study
por: Helwich, Ewa, et al.
Publicado: (2018)

Dose Effect of Poractant Alfa in Neonatal RDS: Analysis of Combined Data from Three Prospective Studies
por: Królak-Olejnik, Barbara, et al.
Publicado: (2020)

Single Nucleotide Polymorphisms Interactions of the Surfactant Protein Genes Associated With Respiratory Distress Syndrome Susceptibility in Preterm Infants
por: Amatya, Shaili, et al.
Publicado: (2021)

Modified lung ultrasound score predicts ventilation requirements in neonatal respiratory distress syndrome
por: Szymański, Piotr, et al.
Publicado: (2021)

Surfactant Therapy for Respiratory Distress Syndrome in High- and Ultra-High-Altitude Settings
por: Duan, Xudong, et al.
Publicado: (2022)

Early Immunomodulatory Effects of Different Natural Surfactant Preparations in Preterms With Respiratory Distress
por: Yalaz, Mehmet, et al.
Publicado: (2022)

Corrigendum: Single nucleotide polymorphisms interactions of the surfactant protein genes associated with respiratory distress syndrome susceptibility in preterm infants
por: Amatya, Shaili, et al.
Publicado: (2022)

Aerosol Delivery of Lung Surfactant and Nasal CPAP in the Treatment of Neonatal Respiratory Distress Syndrome
por: Walther, Frans J., et al.
Publicado: (2022)

Routine use of automated FiO(2) control in Poland: prospective registry and survey
por: Wilinska, M., et al.
Publicado: (2023)

Lung ultrasound to guide the administration of exogenous pulmonary surfactant in respiratory distress syndrome of newborn infants: A retrospective investigation study
por: Liu, Jing, et al.
Publicado: (2022)

The Effect of Initial High vs. Low FiO(2) on Breathing Effort in Preterm Infants at Birth: A Randomized Controlled Trial
por: Dekker, Janneke, et al.
Publicado: (2019)

Aerosolized Surfactant for Preterm Infants with Respiratory Distress Syndrome
por: Brasher, Mandy, et al.
Publicado: (2021)

Diagnostic Challenges in Neonatal Respiratory Distress—Congenital Surfactant Metabolism Dysfunction Caused by ABCA3 Mutation
por: Rogulska, Justyna, et al.
Publicado: (2022)

Outcome of Very Premature Newborn Receiving an Early Second Dose of Surfactant for Persistent Respiratory Distress Syndrome
por: Greiner, Eva, et al.
Publicado: (2021)

The Common Haplotype GATGACA in Surfactant-Protein B Gene Is Protective for Respiratory Distress Syndrome in Preterm Neonates
por: Mikolajcikova, Silvia, et al.
Publicado: (2022)

Minimally Invasive Surfactant Administration for the Treatment of Neonatal Respiratory Distress Syndrome: A Multicenter Randomized Study in China
por: Han, Tongyan, et al.
Publicado: (2020)

Effect of Nasal Continuous Airway Pressure With and Without Surfactant Administration for the Treatment of Respiratory Distress Syndrome in Preterm Neonates
por: Malibary, Husam, et al.
Publicado: (2023)

Trial of aerosolised surfactant for preterm infants with respiratory distress syndrome
por: Jardine, Luke, et al.
Publicado: (2022)

Comparison of mortality and short-term outcomes between classic, intubation-surfactant-extubation, and less invasive surfactant administration methods of surfactant replacement therapy
por: Kim, Seung Yeon, et al.
Publicado: (2023)

CSF Surfactant Protein Changes in Preterm Infants After Intraventricular Hemorrhage
por: Krause, Matthias, et al.
Publicado: (2020)

The Role of Surfactant in Respiratory Distress Syndrome
por: Ma, Christopher Cheng-Hwa, et al.
Publicado: (2012)

Early Surfactant Therapy for Respiratory Distress Syndrome in Very Preterm Infants
por: Cucerea, Manuela, et al.
Publicado: (2023)

Surfactant treatment before first breath for respiratory distress syndrome in preterm lambs: comparison of a peptide-containing synthetic lung surfactant with porcine-derived surfactant
por: van Zyl, Johann M, et al.
Publicado: (2013)

Cerebral oxygenation and bioelectrical activity in preterm infants during surfactant replacement therapy with porcine and bovine preparations
por: Szczapa, Tomasz, et al.
Publicado: (2020)

The predictive value of FiO2 for outcome of children with respiratory syncytial virus-induced acute respiratory distress syndrome
por: Schene, K.M., et al.
Publicado: (2013)

The Efficacy of Surfactant Replacement Therapy in the Growth-Restricted Preterm Infant: What is the Evidence?
por: Malhotra, Atul, et al.
Publicado: (2014)

Evaluation of the impact of oximeter averaging times on automated FiO(2) control in routine NICU care: a randomized cross-over study
por: Janota, J., et al.
Publicado: (2023)

Surfactants in Acute Respiratory Distress Syndrome in Infants and Children: Past, Present and Future
por: Amigoni, Angela, et al.
Publicado: (2017)

Surfactant preparations for preterm infants with respiratory distress syndrome: past, present, and future
por: Jeon, Ga Won
Publicado: (2019)

Practical considerations when administering surfactants to preterm infants with respiratory distress syndrome
por: Jo, Heui Seung
Publicado: (2019)

Profound Effect of Pulmonary Surfactant on the Treatment of Preterm Infants with Respiratory Distress Syndrome
por: Liu, Lin, et al.
Publicado: (2022)

Variation in the PaO(2)/FiO(2 )ratio with FiO(2): mathematical and experimental description, and clinical relevance
por: Karbing, Dan S, et al.
Publicado: (2007)

Surfactant Status and Respiratory Outcome in Premature Infants Receiving Late Surfactant Treatment
por: Ballard, Philip L, et al.
Publicado: (2018)

Assessment of PaO(2)/FiO(2) for stratification of patients with moderate and severe acute respiratory distress syndrome
por: Villar, Jesús, et al.
Publicado: (2015)

Endotracheal Surfactant Combined With Budesonide for Neonatal ARDS
por: Deliloglu, Burak, et al.
Publicado: (2020)

Effects of High-Frequency Oscillatory Ventilation With Volume Guarantee During Surfactant Treatment in Extremely Low Gestational Age Newborns With Respiratory Distress Syndrome: An Observational Study
por: Tana, Milena, et al.
Publicado: (2022)

Can surfactants affect mortality and morbidity in term infants with respiratory failure?
por: ALKAN ÖZDEMİR, Senem, et al.
Publicado: (2022)

Surfactant proteins gene variants in premature newborn infants with severe respiratory distress syndrome
por: Somaschini, Marco, et al.
Publicado: (2017)

Transient intubation for surfactant administration in the treatment of respiratory distress syndrome in extremely premature infants
por: Koh, Ji Won, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_89nkrfnu4pp1tiptuv30lq03ua